BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24100446)

  • 1. Primitive CML cell expansion relies on abnormal levels of BMPs provided by the niche and on BMPRIb overexpression.
    Laperrousaz B; Jeanpierre S; Sagorny K; Voeltzel T; Ramas S; Kaniewski B; Ffrench M; Salesse S; Nicolini FE; Maguer-Satta V
    Blood; 2013 Nov; 122(23):3767-77. PubMed ID: 24100446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
    Lefort S; Maguer-Satta V
    Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new signaling cascade linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcome.
    Voeltzel T; Flores-Violante M; Zylbersztejn F; Lefort S; Billandon M; Jeanpierre S; Joly S; Fossard G; Milenkov M; Mazurier F; Nehme A; Belhabri A; Paubelle E; Thomas X; Michallet M; Louache F; Nicolini FE; Caron de Fromentel C; Maguer-Satta V
    Cell Death Dis; 2018 Sep; 9(10):1011. PubMed ID: 30262802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immature CML cells implement a BMP autocrine loop to escape TKI treatment.
    Grockowiak E; Laperrousaz B; Jeanpierre S; Voeltzel T; Guyot B; Gobert S; Nicolini FE; Maguer-Satta V
    Blood; 2017 Dec; 130(26):2860-2871. PubMed ID: 29138221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response.
    Chapellier M; Bachelard-Cascales E; Schmidt X; Clément F; Treilleux I; Delay E; Jammot A; Ménétrier-Caux C; Pochon G; Besançon R; Voeltzel T; Caron de Fromentel C; Caux C; Blay JY; Iggo R; Maguer-Satta V
    Stem Cell Reports; 2015 Feb; 4(2):239-54. PubMed ID: 25601208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP2, BMP4, noggin, BMPRIA, BMPRIB, and BMPRII are differentially expressed in the adult rat spinal cord.
    Miyagi M; Mikawa S; Sato T; Hasegawa T; Kobayashi S; Matsuyama Y; Sato K
    Neuroscience; 2012 Feb; 203():12-26. PubMed ID: 22202460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term exposure to bisphenol A or benzo(a)pyrene alters the fate of human mammary epithelial stem cells in response to BMP2 and BMP4, by pre-activating BMP signaling.
    Clément F; Xu X; Donini CF; Clément A; Omarjee S; Delay E; Treilleux I; Fervers B; Le Romancer M; Cohen PA; Maguer-Satta V
    Cell Death Differ; 2017 Jan; 24(1):155-166. PubMed ID: 27740625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myeloid leukaemia cells require the bone morphogenic protein pathway for cell cycle progression and self-renewal.
    Toofan P; Busch C; Morrison H; O'Brien S; Jørgensen H; Copland M; Wheadon H
    Cell Death Dis; 2018 Sep; 9(9):927. PubMed ID: 30206237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.
    Diaz-Blanco E; Bruns I; Neumann F; Fischer JC; Graef T; Rosskopf M; Brors B; Pechtel S; Bork S; Koch A; Baer A; Rohr UP; Kobbe G; von Haeseler A; Gattermann N; Haas R; Kronenwett R
    Leukemia; 2007 Mar; 21(3):494-504. PubMed ID: 17252012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCR-ABL-induced deregulation of the IL-33/ST2 pathway in CD34+ progenitors from chronic myeloid leukemia patients.
    Levescot A; Flamant S; Basbous S; Jacomet F; Féraud O; Anne Bourgeois E; Bonnet ML; Giraud C; Roy L; Barra A; Chomel JC; Turhan A; Guilhot F; Girard JP; Gombert JM; Herbelin A
    Cancer Res; 2014 May; 74(10):2669-76. PubMed ID: 24675360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quiescent fraction of chronic myeloid leukemic stem cells depends on BMPR1B, Stat3 and BMP4-niche signals to persist in patients in remission.
    Jeanpierre S; Arizkane K; Thongjuea S; Grockowiak E; Geistlich K; Barral L; Voeltzel T; Guillemin A; Gonin-Giraud S; Gandrillon O; Nicolini FE; Mead AJ; Maguer-Satta V; Lefort S
    Haematologica; 2021 Jan; 106(1):111-122. PubMed ID: 32001529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia.
    Wisniewski D; Strife A; Berman E; Clarkson B
    Leukemia; 1996 Feb; 10(2):229-37. PubMed ID: 8637231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BMP pathway: A unique tool to decode the origin and progression of leukemia.
    Zylbersztejn F; Flores-Violante M; Voeltzel T; Nicolini FE; Lefort S; Maguer-Satta V
    Exp Hematol; 2018 May; 61():36-44. PubMed ID: 29477370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development.
    Fatehi AN; van den Hurk R; Colenbrander B; Daemen AJ; van Tol HT; Monteiro RM; Roelen BA; Bevers MM
    Theriogenology; 2005 Feb; 63(3):872-89. PubMed ID: 15629804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).
    Gentil M; Hugues P; Desterke C; Telliam G; Sloma I; Souza LEB; Baykal S; Artus J; Griscelli F; Guerci A; Johnson-Ansah H; Foudi A; Bennaceur-Griscelli A; Turhan AG
    PLoS One; 2018; 13(8):e0200923. PubMed ID: 30091999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between BMP4 and IL-7 in human intrathymic precursor cells.
    Varas A; Sacedón R; Hidalgo L; Martínez VG; Valencia J; Cejalvo T; Zapata A; Hernández-López C; Vicente A
    Cell Cycle; 2009 Dec; 8(24):4119-26. PubMed ID: 19923894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered BMP2/4 Signaling in Stem Cells and Their Niche: Different Cancers but Similar Mechanisms, the Example of Myeloid Leukemia and Breast Cancer.
    Guyot B; Lefort S; Voeltzel T; Pécheur EI; Maguer-Satta V
    Front Cell Dev Biol; 2021; 9():787989. PubMed ID: 35047500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell biology of CML--a model linking the chronic and terminal phases.
    Gordon MY
    Leuk Lymphoma; 1993; 11 Suppl 1():93-100. PubMed ID: 8251924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells.
    Haubold M; Weise A; Stephan H; Dünker N
    Int J Biol Sci; 2010 Nov; 6(7):700-15. PubMed ID: 21152263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of estrogen receptor α-36 expression by bone morphogenetic protein 2 in breast cancer cell lines.
    Wang D; Huang P; Zhu B; Sun L; Huang Q; Wang J
    Mol Med Rep; 2012 Sep; 6(3):591-6. PubMed ID: 22711074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.